These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31778467)

  • 1. Loss of tolerance 5 days after discontinuing sulphonamide introduced via desensitization in delayed reaction.
    Pereira ARF; Aun MV; Kelmann NCP; Motta AA; Kalil J; Giavina-Bianchi P
    Einstein (Sao Paulo); 2020; 18():eRC5002. PubMed ID: 31778467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization to trimethoprim sulfamethoxazole in patients with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia.
    White MV; Haddad ZH; Brunner E; Sainz C
    Ann Allergy; 1989 Mar; 62(3):177-9. PubMed ID: 2522290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethoprim-sulfamethoxazole desensitization in AIDS.
    Papakonstantinou G; Füessl H; Hehlmann R
    Klin Wochenschr; 1988 Apr; 66(8):351-3. PubMed ID: 3260637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful oral desensitization to trimethoprim-sulfamethoxazole in acquired immune deficiency syndrome.
    Kalanadhabhatta V; Muppidi D; Sahni H; Robles A; Kramer M
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):394-400. PubMed ID: 8933778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim associated fixed drug eruption.
    Hughes BR; Holt PJ; Marks R
    Br J Dermatol; 1987 Feb; 116(2):241-2. PubMed ID: 2950916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus.
    Caumes E; Guermonprez G; Lecomte C; Katlama C; Bricaire F
    Arch Dermatol; 1997 Apr; 133(4):465-9. PubMed ID: 9126010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful desensitization of two patients who previously developed Stevens-Johnson syndrome while receiving trimethoprim-sulfamethoxazole.
    Douglas R; Spelman D; Czarny D; O'Hehir RE
    Clin Infect Dis; 1997 Dec; 25(6):1480. PubMed ID: 9431406
    [No Abstract]   [Full Text] [Related]  

  • 8. Trimethoprim-sulfamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions.
    Kletzel M; Beck S; Elser J; Shock N; Burks W
    Am J Dis Child; 1991 Dec; 145(12):1428-9. PubMed ID: 1688295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful desensitization in a child with delayed cotrimoxazole hypersensitivity: A case report.
    D'Amelio CM; Del Pozo JL; Vega O; Madamba R; Gastaminza G
    Pediatr Allergy Immunol; 2016 May; 27(3):320-1. PubMed ID: 26660294
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children.
    Palusci VJ; Kaul A; Lawrence RM; Haines KA; Kwittken PL
    Pediatr Infect Dis J; 1996 May; 15(5):456-60. PubMed ID: 8724071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization to co-trimoxazole in a patient with fixed drug eruption.
    Patriarca G; Schiavino D; Buonomo A; Aruanno A; Altomonte G; Nucera E
    J Investig Allergol Clin Immunol; 2008; 18(4):309-11. PubMed ID: 18714541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixed drug eruptions due to co-trimoxazole.
    Lim JT; Chan HL
    Ann Acad Med Singap; 1992 May; 21(3):408-10. PubMed ID: 1416793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized erythematous skin eruptions due to trimethoprim itself and co-trimoxazole.
    Hattori N; Hino H
    J Dermatol; 1998 Apr; 25(4):269-71. PubMed ID: 9609988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of pneumocystis carinii pneumonia after trimethoprim-sulfamethoxazole desensitization.
    Papakonstantinou G; Füessl H; Matuschke A; Hehlmann R
    Klin Wochenschr; 1989 Mar; 67(5):316. PubMed ID: 2785231
    [No Abstract]   [Full Text] [Related]  

  • 15. Fixed drug eruption of the penis due to co-trimoxazole.
    Amir J; Shuper A; Varsano I; Livni E; Mimouni M
    Drug Intell Clin Pharm; 1987 Jan; 21(1 Pt 1):41-2. PubMed ID: 2949954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection.
    Belchi-Hernandez J; Espinosa-Parra FJ
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):355-8. PubMed ID: 8612118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Hypersensitivity to Trimethoprim-Sulfamethoxazole With an Ultrarapid Desensitization Protocol in HIV Infection.
    Villarreal-González RV; González-Díaz SN; Canel Paredes A; De Lira-Quezada CE; Rocha-Silva GK; López Méndez A
    J Investig Allergol Clin Immunol; 2021 Feb; 32(1):66-68. PubMed ID: 34014167
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical provocation of fixed drug eruption due to sulphamethoxazole.
    Oleaga JM; Aguirre A; González M; Diaz-Pérez JL
    Contact Dermatitis; 1993 Sep; 29(3):155. PubMed ID: 8222629
    [No Abstract]   [Full Text] [Related]  

  • 19. Trimethoprim/sulfamethoxazole-induced hypersensitivity syndrome.
    Hicks ME; Smith CL; Stein GE
    Ann Pharmacother; 1997 Oct; 31(10):1259. PubMed ID: 9337454
    [No Abstract]   [Full Text] [Related]  

  • 20. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus.
    Marsh BJ
    Clin Infect Dis; 1997 Sep; 25(3):754-6. PubMed ID: 9314486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.